?. R. Bourette and J. A. Rohrschneider, Early Events in M-CSF Receptor Signaling, Growth Factors, vol.385, issue.3, pp.155-166, 2000.
DOI : 10.1126/science.7701324

URL : https://hal.archives-ouvertes.fr/hal-00192992

?. F. and E. R. Stanley, CSF-1 regulation of the wandering macrophage: complexity in action, Trends Cell Biol, vol.14, pp.628-638, 2004.

?. H. Lin, E. Lee, K. Hestir, C. Leo, M. Huang et al., Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular Proteome, Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular Proteome, pp.807-811, 2008.
DOI : 10.1182/blood.V99.1.111

?. E. Foucher, S. Blanchard, L. Preisser, E. Garo, N. Ifrah et al., IL-34 Induces the Differentiation of Human Monocytes into Immunosuppressive Macrophages. Antagonistic Effects of GM-CSF and IFN??, IL-34 Induces the Differentiation of Human Monocytes into Immunosuppressive Macrophages, Antagonistic Effects of GM-CSF and IFN?, p.56045, 2013.
DOI : 10.1371/journal.pone.0056045.s004

?. M. Baud-'huin, R. Renault, C. Charrier, A. Riet, A. Moreau et al., Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis, J. Pathol, pp.221-77, 2010.

?. M. Chemel, B. L. Goff, R. Brion, C. Cozic, M. Berreur et al., Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients, Annals of the Rheumatic Diseases, vol.71, issue.1, pp.71-50, 2012.
DOI : 10.1136/annrheumdis-2011-200096

URL : https://hal.archives-ouvertes.fr/inserm-00667486

?. E. Boström and P. Lundberg, The Newly Discovered Cytokine IL-34 Is Expressed in Gingival Fibroblasts, Shows Enhanced Expression by Pro-Inflammatory Cytokines, and Stimulates Osteoclast Differentiation, PLoS ONE, vol.31, issue.12, p.81665, 2013.
DOI : 10.1371/journal.pone.0081665.t001

?. P. Roth and E. R. Stanley, The Biology of CSF-1 and Its Receptor, Curr. Top. Microbiol. Immunol, vol.181, pp.141-167, 1992.
DOI : 10.1007/978-3-642-77377-8_5

?. J. Felix, J. Elegheert, I. Gutsche, A. V. Shkumatov, Y. Wen et al., Human IL-34 and CSF-1 Establish Structurally Similar Extracellular Assemblies with Their Common Hematopoietic Receptor, Human IL-34 and CSF-1 establish structurally similar extracellular assemblies with their common hematopoietic receptor, pp.528-539, 2013.
DOI : 10.1016/j.str.2013.01.018

URL : https://doi.org/10.1016/j.str.2013.01.018

?. X. Ma, W. Y. Lin, Y. Chen, S. Stawicki, K. Mukhyala et al., Structural Basis for the Dual Recognition of Helical Cytokines IL-34 and CSF-1 by CSF-1R, Structure, vol.20, issue.4, pp.676-687, 2012.
DOI : 10.1016/j.str.2012.02.010

?. C. Sherr, Colony-stimulating factor-1 receptor, Blood, vol.75, pp.1-12, 1990.

?. H. Liu, C. Leo, X. Chen, B. R. Wong, L. T. Williams et al., The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1824, issue.7, pp.938-945, 2012.
DOI : 10.1016/j.bbapap.2012.04.012

?. T. Chihara, S. Suzu, R. Hassan, N. Chutiwitoonchai, M. Hiyoshi et al., IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation, Cell Death Differ, pp.171917-1927, 2010.

?. X. Dai, G. R. Ryan, A. J. Hapel, M. G. Dominguez, R. G. Russell et al., Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects, Blood, vol.99, issue.1, pp.111-120, 2002.
DOI : 10.1182/blood.V99.1.111

?. H. Yoshida, S. Hayashi, T. Kunisada, M. Ogawa, S. Nishikawa et al., The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene, Nature, vol.345, issue.6274, pp.442-444, 1990.
DOI : 10.1038/345442a0

?. W. Wiktor-jedrzejczak, A. Bartocci, A. W. Jr, A. Ferrante, K. W. Ahmed-ansari et al., Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse., Proceedings of the National Academy of Sciences, vol.87, issue.12, pp.4828-4832, 1990.
DOI : 10.1073/pnas.87.12.4828

?. S. Wei, S. Nandi, V. Chitu, Y. G. Yeung, W. Yu et al., Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells, Journal of Leukocyte Biology, vol.88, issue.3, pp.88-495, 2010.
DOI : 10.1189/jlb.1209822

?. F. Ginhoux, M. Greter, M. Leboeuf, S. Nandi, P. See et al., Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages, Science, vol.56, issue.2, pp.841-845, 2010.
DOI : 10.1016/S0301-0082(98)00035-5

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719181/pdf

?. M. Greter, I. Lelios, P. Pelczar, G. Hoeffel, J. Price et al., Stroma-Derived Interleukin-34 Controls the Development and Maintenance of Langerhans Cells and the Maintenance of Microglia, Immunity, vol.37, issue.6, pp.1050-1060, 2012.
DOI : 10.1016/j.immuni.2012.11.001

?. Y. Wang, K. J. Szretter, W. Vermi, S. Gilfillan, C. Rossini et al., IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia, Nature Immunology, vol.165, issue.8, pp.13-753, 2012.
DOI : 10.1016/j.immuni.2011.06.005

?. D. Heymann, Interleukin-34: An enigmatic cytokine, IBMS BoneKEy, vol.7, issue.11, pp.406-413, 2010.
DOI : 10.1138/20100474

?. S. Nandi, S. Gokhan, S. Dai, G. Wei, H. Enikolopov et al., The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation, Developmental Biology, vol.367, issue.2, pp.367-100, 2012.
DOI : 10.1016/j.ydbio.2012.03.026

URL : https://doi.org/10.1016/j.ydbio.2012.03.026

?. J. Vandesompele, K. D. Preter, F. Pattyn, B. Poppe, N. V. Roy et al., Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes, Genome Biol, vol.3, 2002.

?. S. Bustin, V. Benes, J. A. Garson, J. Hellemans, J. Huggett et al., The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments, Clinical Chemistry, vol.55, issue.4, pp.55-611, 2009.
DOI : 10.1373/clinchem.2008.112797

?. F. Tejedor and J. P. Ballesta, Iodination of biological samples without loss of functional activity, Analytical Biochemistry, vol.127, issue.1, pp.143-149, 1982.
DOI : 10.1016/0003-2697(82)90156-7

?. A. Godard, D. Heymann, S. Raher, I. Anegon, M. A. Peyrat et al., High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution, J. Biol. Chem, vol.267, pp.3214-3222, 1992.

?. S. Nandi, M. Cioce, Y. G. Yeung, E. Nieves, L. Tesfa et al., Receptor-type Protein-tyrosine Phosphatase ?? Is a Functional Receptor for Interleukin-34, Journal of Biological Chemistry, vol.269, issue.30, pp.21972-21986, 2013.
DOI : 10.1038/74805

URL : http://www.jbc.org/content/288/30/21972.full.pdf

?. A. Fujikawa, M. Fukada, Y. Makioka, R. Suzuki, J. P. Chow et al., Noda Consensus substrate sequence for protein-tyrosine phosphatase receptor type Z, J. Biol. Chem, pp.286-37137, 2011.
DOI : 10.1074/jbc.m111.270140

URL : http://www.jbc.org/content/286/43/37137.full.pdf

?. J. Couchman, Transmembrane Signaling Proteoglycans, Transmembrane Signaling Proteoglycans, pp.89-114, 2010.
DOI : 10.1146/annurev-cellbio-100109-104126

?. R. Sanderson and M. Bernfield, Molecular polymorphism of a cell surface proteoglycan: distinct structures on simple and stratified epithelia., Proceedings of the National Academy of Sciences, vol.85, issue.24, pp.85-9562, 1988.
DOI : 10.1073/pnas.85.24.9562

?. S. Saunders, M. Jalkanen, S. O. Farrell, and M. Bernfield, Molecular cloning of syndecan, an integral membrane proteoglycan, The Journal of Cell Biology, vol.108, issue.4, pp.1547-1556, 1989.
DOI : 10.1083/jcb.108.4.1547

URL : http://jcb.rupress.org/content/jcb/108/4/1547.full.pdf

?. P. Marynen, J. Zhang, J. J. Cassiman, H. Van-den-berghe, and G. David, Partial primary structure of the 48-and 90-kilodalton core proteins of cell surface-associated heparan sulfate proteoglycans of lung fibroblasts. Prediction of an integral membrane domain and evidence for multiple distinct core proteins at the cell surface of human lung fibroblasts, J. Biol. Chem, vol.264, pp.7017-7024, 1989.

?. D. Carey, D. M. Evans, R. C. Stahl, V. K. Asundi, K. J. Conner et al., Molecular cloning and characterization of N-syndecan, a novel transmembrane heparan sulfate proteoglycan, The Journal of Cell Biology, vol.117, issue.1, pp.191-201, 1992.
DOI : 10.1083/jcb.117.1.191

?. G. David, B. Van-der-schueren, P. Marynen, J. J. Cassiman, and H. , Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells, The Journal of Cell Biology, vol.118, issue.4, pp.961-969, 1992.
DOI : 10.1083/jcb.118.4.961

?. C. Yeaman and A. C. Rapraeger, Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form, Journal of Cellular Physiology, vol.122, issue.2, pp.413-425, 1993.
DOI : 10.1016/S0171-2985(88)80024-X

?. G. Karasneh, M. Ali, and D. Shukla, An Important Role for Syndecan-1 in Herpes Simplex Virus Type-1 Induced Cell-to-Cell Fusion and Virus Spread, PLoS ONE, vol.286, issue.8, p.25252, 2011.
DOI : 10.1371/journal.pone.0025252.t001

?. H. Kresse and E. Schönherr, Proteoglycans of the extracellular matrix and growth control, Journal of Cellular Physiology, vol.124, issue.3, pp.266-274, 2001.
DOI : 10.1083/jcb.124.5.817

?. N. Jastrebova, M. Vanwildemeersch, U. Lindahl, and D. Spillmann, Heparan Sulfate Domain Organization and Sulfation Modulate FGF-induced Cell Signaling, Journal of Biological Chemistry, vol.1773, issue.35, pp.285-26842, 2010.
DOI : 10.1016/j.bbamcr.2006.10.005

URL : http://www.jbc.org/content/285/35/26842.full.pdf

?. R. Takazaki, Y. Shishido, R. Iwamoto, and E. Mekada, Suppression of the Biological Activities of the Epidermal Growth Factor (EGF)-like Domain by the Heparin-binding Domain of Heparin-binding EGF-like Growth Factor, Journal of Biological Chemistry, vol.269, issue.45, pp.279-47335, 2004.
DOI : 10.1016/S0092-8674(02)00940-6

L. E. Kemp, B. Mulloy, and E. Gherardi, Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors, Biochemical Society Transactions, vol.34, issue.3, pp.34-414, 2006.
DOI : 10.1042/BST0340414

?. J. Dai and A. B. Rabie, VEGF: an Essential Mediator of Both Angiogenesis and Endochondral Ossification, Journal of Dental Research, vol.86, issue.10, pp.937-950, 2007.
DOI : 10.1615/JLongTermEffMedImplants.v12.i2.70

?. C. Niehrs, The complex world of WNT receptor signalling, Nature Reviews Molecular Cell Biology, vol.488, issue.12, pp.767-779, 2012.
DOI : 10.1038/nature11282

?. C. Rider, Heparin/heparan sulphate binding in the TGF-?? cytokine superfamily: Figure 1, Biochemical Society Transactions, vol.34, issue.3, pp.34-458, 2006.
DOI : 10.1042/BST0340458

?. N. Sampaio, W. Yu, D. Cox, J. Wyckoff, J. Condeelis et al., Phosphorylation of CSF-1R Y721 mediates its association with PI3K to regulate macrophage motility and enhancement of tumor cell invasion, Journal of Cell Science, vol.124, issue.12, pp.2021-2031, 2011.
DOI : 10.1242/jcs.075309

?. A. Rapraeger, Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-??v??3 integrin complex in tumorigenesis and angiogenesis, FEBS Journal, vol.84, issue.10, pp.2207-2215, 2013.
DOI : 10.1152/physrev.00035.2003

?. S. Massena, G. Christoffersson, E. Hjertström, E. Zcharia, I. Vlodavsky et al., A chemotactif gradient sequestered on endothelial heparan sulfate induces directionnal intraluminal crawling of netutrophils, Blood, vol.116, pp.1942-1931, 2010.

?. B. Mosheimer, N. C. Kaneider, C. Feistritzer, A. M. Djanani, D. H. Sturn et al., Syndecan-1 Is Involved in Osteoprotegerin-Induced Chemotaxis in Human Peripheral Blood Monocytes, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.5, pp.90-2964, 2005.
DOI : 10.1210/jc.2004-1895

URL : https://academic.oup.com/jcem/article-pdf/90/5/2964/10777120/jcem2964.pdf

?. Z. Bensliman-ahmin, F. Poirier, C. Delomenie, A. Lokajczyk, F. Grelac et al., Mechanistic study of the proangiogenic effect of osteoprotegerin, Angiogenesis, vol.389, issue.3, pp.575-593, 2013.
DOI : 10.1042/BJ20042129

?. T. Kelly, L. J. Suva, K. M. Nicks, V. Macleod, and R. D. Sanderson, Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis, Journal of Bone and Mineral Research, vol.105, issue.Suppl, pp.25-1295, 2010.
DOI : 10.1038/bjc.1987.13

URL : http://onlinelibrary.wiley.com/doi/10.1002/jbmr.16/pdf

?. J. Cook, T. Hagemann, and T. , Tumour-associated macrophages and cancer, Current Opinion in Pharmacology, vol.13, issue.4, pp.595-601, 2013.
DOI : 10.1016/j.coph.2013.05.017

?. M. Averbeck, C. Gebbhardt, U. Anderegg, C. Termeer, J. P. Sleeman et al., Swith in syndecan-1 and syndecan-4 expression controls maturation associated dendritic cell motility, Exp. Dermatol, pp.16-580, 2007.
DOI : 10.1111/j.1600-0625.2007.00568.x

?. C. Yeaman and A. C. Rapraeger, Post-transcriptional regulation of syndecan-1 expression by cAMP in peritoneal macrophages, The Journal of Cell Biology, vol.122, issue.4, pp.941-950, 1993.
DOI : 10.1083/jcb.122.4.941